Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog-Reference-Cited by-同舟云学术

Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog

Published:2017-10-16 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zorzella-Pezavento Sofia Fernanda Gonçalves,Mimura Luiza Ayumi Nishiyama,Fraga-Silva Thais Fernanda Campos,Ishikawa Larissa Lumi Watanabe,França Thais Graziela Donegá,Sartori Alexandrina

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference72 articles.

1. The immunopathology of multiple sclerosis: an overview;Lassmann;Brain Pathol,2007

2. Pathogenesis of multiple sclerosis: an update on immunology;Hemmer;Curr Opin Neurol,2002

3. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination;Rostami;J Neurol Sci,2013

4. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis;O’Connor;J Immunol,2008

5. Oligodendrocytes: biology and pathology;Bradl;Acta Neuropathol,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in epicutaneous immunotherapy and potential applications in food allergy;Frontiers in Allergy;2023-10-27

2. Peptide-based immunotherapy in lupus: Where are we now?;Rheumatology and Immunology Research;2023-09-01

3. Oral Administration of Myelin Oligodendrocyte Glycoprotein Attenuates Experimental Autoimmune Encephalomyelitis through Induction of Th2/Treg Cells and Suppression of Th1/Th17 Immune Responses;Current Issues in Molecular Biology;2022-11-18

4. Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?;Neural Regeneration Research;2022

5. Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3+ Tregs;Frontiers in Immunology;2021-02-26